A monoclonal antibody (-mab) already existed in a lab in the Netherlands, because it had been developed for SARS and turned out to work for SARS-CoV-2. But it w

A monoclonal antibody (-mab) already existed in a lab in the Netherlands, because it had been developed for SARS and turned out to work for SARS-CoV-2. But it will take weeks before this can be industrialized, let alone approved.